Brokers have so far granted $1.83 billion margin to the IPO of XPeng (09868.HK)(XPEV.US) on the first day of public offering as at around 6 pm. The IPO was thus over-subscribed by almost 1.4 times based on the fundraising amount of $765 million from the public offering.
KEYMED BIO-B (02162.HK), on the first day of public offering as well, recorded $21.72 billion subscription. The IPO was thus over-subscribed by almost 69 times based on the fundraising amount of $310 million from the public offering.
KEYMED BIO-B (02162.HK), on the first day of public offering as well, recorded $21.72 billion subscription. The IPO was thus over-subscribed by almost 69 times based on the fundraising amount of $310 million from the public offering.